These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33763631)

  • 1. Designing and evaluating contextualized drug-drug interaction algorithms.
    Chou E; Boyce RD; Balkan B; Subbian V; Romero A; Hansten PD; Horn JR; Gephart S; Malone DC
    JAMIA Open; 2021 Jan; 4(1):ooab023. PubMed ID: 33763631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record.
    Wright A; Aaron S; Seger DL; Samal L; Schiff GD; Bates DW
    J Gen Intern Med; 2018 Nov; 33(11):1868-1876. PubMed ID: 29766382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study.
    Horn J; Ueng S
    Ann Pharmacother; 2019 Nov; 53(11):1087-1092. PubMed ID: 31296026
    [No Abstract]   [Full Text] [Related]  

  • 6. High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study.
    Cornu P; Phansalkar S; Seger DL; Cho I; Pontefract S; Robertson A; Bates DW; Slight SP
    Int J Med Inform; 2018 Mar; 111():165-171. PubMed ID: 29425628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured override reasons for drug-drug interaction alerts in electronic health records.
    Wright A; McEvoy DS; Aaron S; McCoy AB; Amato MG; Kim H; Ai A; Cimino JJ; Desai BR; El-Kareh R; Galanter W; Longhurst CA; Malhotra S; Radecki RP; Samal L; Schreiber R; Shelov E; Sirajuddin AM; Sittig DF
    J Am Med Inform Assoc; 2019 Oct; 26(10):934-942. PubMed ID: 31329891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Acceptance of Interruptive Medication Alerts in an Electronic Decision Support System Differs between Different Alert Types.
    Bittmann JA; Rein EK; Metzner M; Haefeli WE; Seidling HM
    Methods Inf Med; 2021 Dec; 60(5-06):180-184. PubMed ID: 34450669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts.
    McDaniel RB; Burlison JD; Baker DK; Hasan M; Robertson J; Hartford C; Howard SC; Sablauer A; Hoffman JM
    J Am Med Inform Assoc; 2016 Apr; 23(e1):e138-41. PubMed ID: 26499101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Overridden Medication-related Clinical Decision Support in the Intensive Care Unit between a Commercial System and a Legacy System.
    Wong A; Wright A; Seger DL; Amato MG; Fiskio JM; Bates D
    Appl Clin Inform; 2017 Aug; 8(3):866-879. PubMed ID: 28832067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.
    Phansalkar S; van der Sijs H; Tucker AD; Desai AA; Bell DS; Teich JM; Middleton B; Bates DW
    J Am Med Inform Assoc; 2013 May; 20(3):489-93. PubMed ID: 23011124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients.
    Wasylewicz ATM; van de Burgt BWM; Manten T; Kerskes M; Compagner WN; Korsten EHM; Egberts TCG; Grouls RJE
    Clin Pharmacol Ther; 2022 Aug; 112(2):382-390. PubMed ID: 35486411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an optimized context-aware clinical decision support system for drug-drug interaction screening.
    Muylle KM; Gentens K; Dupont AG; Cornu P
    Int J Med Inform; 2021 Apr; 148():104393. PubMed ID: 33486355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.